HOME >> BIOLOGY >> NEWS
Screening approach leads to discovery of gene linked to breast cancer

BOSTON -- Using a novel three-part screening process, scientists at Dana-Farber Cancer Institute have identified a gene that is made inappropriately in about a third of all breast cancers. The discovery, reached in collaboration with researchers at Brigham and Women's Hospital (BWH) and the Broad Institute of Harvard and MIT, is reported in the June 15, 2007 issue of the journal Cell.

Unlike breast cancer-susceptibility genes such as BRCA1 and BRCA2, the newly identified gene, called IKBKE, is not inherited in a mutated form that increases the risk of developing breast cancer at an early age. Rather, the mutation arises during a woman's life, causing an overproduction of the IKBKE protein. That, in turn, spurs cell growth and proliferation. The mutation is found in 30-40 percent of all breast cancers, making it a prime target for future drugs for the disease.

The method used to home in on the gene -- a combination of three existing experimental approaches -- offers an elegant solution to one of the major hurdles of genome-age research: how to sift through the multitude of genes identified by advanced screening technology as potential cancer-causers to find those with the most profound role in the disease. As such, the new approach can be used to discover genes associated with many types of cancers, the study's authors state.

The genetic material within many human cancer cells is in such disarray that there can be numerous gene mutations," says the study's co-senior author, William Hahn, MD, PhD, of Dana-Farber, BWH, and the Broad Institute. Current technologies -- particularly 'microarray' sensors, which read the activity and changes in thousands of genes at a time enable us to locate dozens or even hundreds of gene abnormalities in cancer cells. The challenge is to winnow this group to find the genes most centrally involved in cancer initiation and maintenance.

"In the current study, we used several complementary approach
'"/>

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
14-Jun-2007


Page: 1 2 3

Related biology news :

1. Screening for fragile skin
2. Screening for complex genetic interactions
3. Screening blood for West Nile virus
4. Screening chest x-ray detects early-stage lung cancers at high rates, study results show
5. NIH awards $11.9 M to The Burnham Institute to establish the San Diego Chemical Screening Center
6. Screening for genetic disorders: Need to avoid anxiety
7. Researchers use new approach to predict protein function
8. New approach to pulmonary hypertension shows promise
9. Personalized approach to ovarian stimulation achieves high ART pregnancy rates
10. New approaches to endometriosis treatment -- mouse experiments point the way
11. Reconstructing the biology of extinct species: A new approach

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , ... strain level, today announced that the company will debut a novel new DNA isolation ... , The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... manufacture lifesaving mature red blood cells from stem cells. The red blood ... blood cells, under strictly controlled conditions, for transfusion therapy and replaces the need ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... cold chain operations, developing transport validation strategies, supporting global regulatory applications, and ... 5000 and the Houston Business Journal as a fastest growing company, and ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... ... the exclusive distributor to food and beverage manufactures within North America. Both Lifecycle ... suppliers. This agreement will allow each company to pool their collective resources and ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, ... Kits . The new Salivary Total Human IgG Assay Kit exemplifies ... G in saliva, researchers can extend the accuracy and ease of use of ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading ... strategic investors led by Halma plc , a FTSE 100 global group ... GII LLC, and WSJ Joshua Fund. A representative from Halma will join the ...
(Date:1/24/2020)... ... January 24, 2020 , ... The impact of ... diagnostics, therapeutics, laboratory and clinical services during the first two decades of the ... And as Slone Partners celebrates its 20th anniversary this year, its ...
Breaking Biology Technology:
Cached News: